Phapros Profit Surges 311% as Higher Sales and Efficiency Provide Support
JAKARTA — PT Phapros Tbk recorded net profit of Rp31.60 billion through September 2026, up 311.58% from Rp7.68 billion in the same period last year. The increase in profit exceeded sales growth, which was 15.07% to Rp786.57 billion.
Phapros President Director Intan Abdams Katoppo said the company also improved its operating efficiency during January-September 2026. Earnings before interest, tax, depreciation and amortisation (EBITDA) grew 30.26% to Rp117.66 billion.
“EBITDA margin rose to 15% from 13.2%, showing that Phapros’ production operations are becoming more efficient and profitability is strengthening. Gross profit margin also increased thanks to improvements in the product portfolio and production processes at the factory,” Intan said in a written statement in Jakarta on Monday (2 November 2026).
Profit rose as production costs grew more slowly than sales. The cost of goods sold (COGS) for the first nine months of 2026 was Rp384.04 billion, up 11.04% from Rp345.86 billion in the same period last year.
“The COGS-to-sales ratio fell to 48.8% from 50.6%, indicating that production is becoming more efficient,” Intan said.
With production costs better controlled, Phapros’ gross profit increased 19.19% to Rp402.53 billion from Rp337.72 billion. Gross profit margin also rose to 51.2% from 49.4%.
Intan said Phapros’ sales in January-September 2026 reached Rp786.57 billion, up from Rp683.58 billion in the same period last year. This continued the sales growth recorded throughout 2025, when sales reached Rp940.88 billion, a 26.34% year-on-year increase.
Higher sales and cost controls also helped Phapros’ operating profit grow 55.90% to Rp80.97 billion. Operating profit in the same period last year was Rp51.94 billion.
Pre-tax profit rose 233.59% to Rp48.65 billion from Rp14.58 billion in January-September 2025.
“Net profit surged 311.58% to Rp31.60 billion from Rp7.68 billion in the same period last year,” Intan added.
In terms of cash flow, Phapros recorded net cash from operating activities of Rp129.96 billion, up 142.85% from Rp53.51 billion in the same period last year. Cash and cash equivalents as at 30 September 2026 also increased 70.54% to Rp157.54 billion from Rp92.38 billion as at 30 September 2025.
“Total assets rose 4.74% to Rp1.45 trillion from Rp1.39 trillion as at 31 December 2025,” she said.
Intan said the company’s performance growth since 2025 had been supported by stronger working capital, cost controls, development of its product portfolio and business, and the transformation of its systems and business processes.
“The increase in EBITDA margin shows that our operations are becoming more efficient and, of course, profitability is strengthening, enabling Phapros to continue contributing to the health of the Indonesian public,” she said.
As the company closes the third quarter of 2026, Intan said it would continue managing the business, developing its product portfolio, and improving operational efficiency and reliability.
“The company will remain focused on creating long-term value for all stakeholders, including shareholders,” Intan said.
Source: jawawa.id (https://jawawa.id/newsitem/phapros-profit-surges-311-as-higher-sales-and-efficiency-provide-support-1793609528)
Originally published by Republika (https://ekonomi.republika.co.id/berita/tnv7q4416/laba-phapros-melonjak-311-persen-kenaikan-penjualan-dan-efisiensi-jadi-penopang), translated from Indonesian